Summary
Background The effectiveness of different strategies in addressing the COVID-19 pandemic has been assessed, but there is still not enough evidence in Asian countries. This study aims to examine the factors influencing the trajectory of COVID-19 evolution in Asia, to provide insights for optimizing public health policies.
Methods In this longitudinal analysis, we combined COVID-19 cases and vaccination percentages from Our Word in Data with the policy stringency index from the Oxford COVID-19 Government Response Tracker for 12 Asian countries between January 1, 2021, and September 30, 2022. An agglomerative hierarchical cluster analysis (HCA) was conducted to identify countries with similar COVID-19 evolution trajectories. We also investigated the potential impact of seasonal variations on the virus’ trajectory. The relationship between the level of policy response, vaccination coverage, and COVID-19 cases was explored using Generalized Additive Models (GAMs).
Findings There were noticeable differences in the evolution trajectory of COVID-19 among the countries. The 12 Asian countries were grouped into two clusters based on evolutionary similarities. Cluster 1 consisted of West Asian countries (Azerbaijan, Turkey, Bahrain, Israel and Lebanon); while Cluster 2 included Japan, South Korea, Singapore, Malaysia, Thailand, Cambodia and Indonesia. The analysis revealed that the stringency index and vaccination coverage were associated with a statistically significant impact (both P values < 0·0001) on the evolution trajectory of COVID-19 (adjR2=0·54). The dose-response relationships demonstrated that the continuous high levels of stringency index (≥87·6) or vaccination coverage (≥ 42·0%) have led to a decrease in COVID-19 infection rates. In early 2021, the adjR2 increased to 0·93 for all countries. Furthermore, the adjR2 for Cluster 1 and Cluster 2 were 0·86 and 0·90 respectively. All GAMs models have significantly improved compared to null model (P values <0·0001).
Interpretation By strengthening vaccination ahead of susceptible seasons and enhancing personal self-protection measures, the transmission of COVID-19 among the population can be reduced even during the highly infectious Omicron era.
Funding Senior Talent Startup Fund of Nanchang University
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by Senior Talent Startup Fund of Nanchang University
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced are available online at Our World in Data and the Oxford COVID-19 Government Response Tracker
https://ourworldindata.org/coronavirus
https://www.bsg.ox.ac.uk/research/covid-19-government-response-tracker
